CRS
Overvalued by 94% based on the discounted cash flow analysis.
Market cap | $12.63 Billion |
---|---|
Enterprise Value | $13.18 Billion |
Dividend Yield | $0.8 (0.315308213778969%) |
Earnings per Share | $3.75 |
Beta | 1.37 |
Outstanding Shares | 50,200,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 35.59 |
---|---|
PEG | 2.52 |
Price to Sales | 4.58 |
Price to Book Ratio | 7.59 |
Enterprise Value to Revenue | 4.51 |
Enterprise Value to EBIT | 26.68 |
Enterprise Value to Net Income | 36 |
Total Debt to Enterprise | 0.05 |
Debt to Equity | 0.39 |
No data
No data